Abstract
IntroductionLyme disease (LD) is the most frequent tick-borne disease in the moderate climates of Europe. This study will inform the phase III efficacy study for Pfizer and Valneva’s investigational Lyme...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have